Samuel M Kim1, Di Zhao1, Andrea L C Schneider1, Sai Krishna Korada1, Pamela L Lutsey1, Eliseo Guallar1, Alvaro Alonso1, B Gwen Windham1, Rebecca F Gottesman1, Erin D Michos2. 1. From the Ciccarone Center for the Prevention of Heart Disease (S.M.K., E.D.M.) and Department of Neurology (A.L.C.S., R.F.G.), Johns Hopkins University School of Medicine; Department of Epidemiology (D.Z., E.G., R.F.G., E.D.M.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Northeast Ohio Medical University (S.K.K.), Rootstown; Division of Epidemiology and Community Health (P.L.L.), School of Public Health, University of Minnesota, Minneapolis; Department of Epidemiology (A.A.), Rollins School of Public Health, Emory University, Atlanta, GA; and Department of Medicine (B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson. 2. From the Ciccarone Center for the Prevention of Heart Disease (S.M.K., E.D.M.) and Department of Neurology (A.L.C.S., R.F.G.), Johns Hopkins University School of Medicine; Department of Epidemiology (D.Z., E.G., R.F.G., E.D.M.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Northeast Ohio Medical University (S.K.K.), Rootstown; Division of Epidemiology and Community Health (P.L.L.), School of Public Health, University of Minnesota, Minneapolis; Department of Epidemiology (A.A.), Rollins School of Public Health, Emory University, Atlanta, GA; and Department of Medicine (B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson. edonnell@jhmi.edu.
Abstract
OBJECTIVE: We hypothesized that elevated parathyroid hormone (PTH) levels will be independently associated with 20-year cognitive decline in a large population-based cohort. METHODS: We studied 12,964 middle-aged white and black ARIC participants without a history of prior stroke who, in 1990-1992 (baseline), had serum PTH levels measured and cognitive function testing, with repeat cognitive testing performed at up to 2 follow-up visits. Cognitive testing included the Delayed Word Recall, the Digit Symbol Substitution, and the Word Fluency tests, which were summed as a global Z score. Using mixed-effects models, we compared the relative decline in individual and global cognitive scores between each of the top 3 quartiles of PTH levels to the reference bottom quartile. We adjusted for demographic variables, education, vascular risk factors, and levels of calcium, phosphate, and vitamin D. We imputed missing covariate and follow-up cognitive data to account for attrition. RESULTS: The mean (SD) age of our cohort was 57 (6) years, 57% were women, and 24% were black. There was no cross-sectional association of elevated PTH with cognitive global Z score at baseline (p > 0.05). Over a median of 20.7 years, participants in each PTH quartile showed a decline in cognitive function. However, there was no significant difference in cognitive decline between each of the top 3 quartiles and the lowest reference quartile (p > 0.05). In a subset, there was also no association of higher mid-life PTH levels with late-life prevalent adjudicated dementia (p > 0.05). CONCLUSIONS: Our work does not support an independent influence of PTH on cognitive decline in this population-based cohort study.
OBJECTIVE: We hypothesized that elevated parathyroid hormone (PTH) levels will be independently associated with 20-year cognitive decline in a large population-based cohort. METHODS: We studied 12,964 middle-aged white and black ARIC participants without a history of prior stroke who, in 1990-1992 (baseline), had serum PTH levels measured and cognitive function testing, with repeat cognitive testing performed at up to 2 follow-up visits. Cognitive testing included the Delayed Word Recall, the Digit Symbol Substitution, and the Word Fluency tests, which were summed as a global Z score. Using mixed-effects models, we compared the relative decline in individual and global cognitive scores between each of the top 3 quartiles of PTH levels to the reference bottom quartile. We adjusted for demographic variables, education, vascular risk factors, and levels of calcium, phosphate, and vitamin D. We imputed missing covariate and follow-up cognitive data to account for attrition. RESULTS: The mean (SD) age of our cohort was 57 (6) years, 57% were women, and 24% were black. There was no cross-sectional association of elevated PTH with cognitive global Z score at baseline (p > 0.05). Over a median of 20.7 years, participants in each PTH quartile showed a decline in cognitive function. However, there was no significant difference in cognitive decline between each of the top 3 quartiles and the lowest reference quartile (p > 0.05). In a subset, there was also no association of higher mid-life PTH levels with late-life prevalent adjudicated dementia (p > 0.05). CONCLUSIONS: Our work does not support an independent influence of PTH on cognitive decline in this population-based cohort study.
Authors: Emil Hagström; Tommy Ahlström; Johan Ärnlöv; Anders Larsson; Håkan Melhus; Per Hellman; Lars Lind Journal: Atherosclerosis Date: 2014-12-20 Impact factor: 5.162
Authors: Cornelia M E Dotzenrath; Ana Karena Kaetsch; Henrich Pfingsten; Kenko Cupisti; Norbert Weyerbrock; Alexander Vossough; Pablo E Verde; Christian Ohmann Journal: World J Surg Date: 2006-05 Impact factor: 3.352
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Cortney Bosworth; Michael C Sachs; Daniel Duprez; Andrew N Hoofnagle; Joachim H Ix; David R Jacobs; Carmen A Peralta; David S Siscovick; Bryan Kestenbaum; Ian H de Boer Journal: Clin Endocrinol (Oxf) Date: 2013-05-20 Impact factor: 3.478
Authors: Rebeccah A McKibben; Di Zhao; Pamela L Lutsey; Andrea L C Schneider; Eliseo Guallar; Thomas H Mosley; Erin D Michos Journal: J Clin Endocrinol Metab Date: 2015-10-28 Impact factor: 5.958
Authors: Stephanie Wang; Oluwaseun E Fashanu; Di Zhao; Eliseo Guallar; Rebecca F Gottesman; Andrea L C Schneider; John W McEvoy; Faye L Norby; Amer I Aladin; Alvaro Alonso; Erin D Michos Journal: Am J Cardiol Date: 2018-10-21 Impact factor: 2.778
Authors: Erin E Bennett; Katie M Lynch; Xiaohui Xu; Eun Sug Park; Qi Ying; Jingkai Wei; Richard L Smith; James D Stewart; Eric A Whitsel; Melinda C Power Journal: Health Place Date: 2022-03-02 Impact factor: 4.931
Authors: A Sardella; F Bellone; N Morabito; S Minisola; G Basile; F Corica; A Catalano Journal: J Endocrinol Invest Date: 2020-09-14 Impact factor: 4.256
Authors: Oluwaseun E Fashanu; Di Zhao; Andrea L C Schneider; Andreea M Rawlings; A Richey Sharrett; Pamela L Lutsey; Rebecca F Gottesman; Alden L Gross; Eliseo Guallar; Alvaro Alonso; Thomas H Mosley; Erin D Michos Journal: BMC Neurol Date: 2019-10-22 Impact factor: 2.474